Literature DB >> 12093666

Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology.

Michael F Marmor, Ronald E Carr, Michael Easterbrook, Ayad A Farjo, William F Mieler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12093666     DOI: 10.1016/s0161-6420(02)01168-5

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  92 in total

Review 1.  The role of antimalarial agents in the treatment of SLE and lupus nephritis.

Authors:  Senq-J Lee; Earl Silverman; Joanne M Bargman
Journal:  Nat Rev Nephrol       Date:  2011-10-18       Impact factor: 28.314

2.  Hydroxychloroquine screening.

Authors:  A G Lee
Journal:  Br J Ophthalmol       Date:  2005-05       Impact factor: 4.638

3.  Ophthaproblem. Chloroquine or hydroxychloroquine retinopathy.

Authors:  Wei Liu; Sanjay Sharma
Journal:  Can Fam Physician       Date:  2005-05       Impact factor: 3.275

4.  Visual field and multifocal electroretinography and their correlations in patients on hydroxychloroquine therapy.

Authors:  Timothy Y Y Lai; Jasmine W S Ngai; Wai-Man Chan; Dennis S C Lam
Journal:  Doc Ophthalmol       Date:  2006-06-28       Impact factor: 2.379

Review 5.  Ocular adverse effects associated with systemic medications : recognition and management.

Authors:  Ricardo M Santaella; Frederick W Fraunfelder
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 6.  Elderly-onset systemic lupus erythematosus: prevalence, clinical course and treatment.

Authors:  Deana Lazaro
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

7.  High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy.

Authors:  Julio A Rodriguez-Padilla; Thomas R Hedges; Bryan Monson; Vivek Srinivasan; Maciej Wojtkowski; Elias Reichel; Jay S Duker; Joel S Schuman; James G Fujimoto
Journal:  Arch Ophthalmol       Date:  2007-06

8.  Baseline Retinal Examinations in Patients With Systemic Lupus Erythematosus Newly Initiating Hydroxychloroquine Treatment in a US Medicaid Systemic Lupus Erythematosus Population, 2000-2010.

Authors:  Tzu-Chieh Lin; Michael F Marmor; Medha Barbhaiya; Hongshu Guan; Sarah K Chen; Candace H Feldman; Karen H Costenbader
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-11       Impact factor: 4.794

9.  Chloroquine and hydroxychloroquine retinopathy-related risk factors in a Turkish cohort.

Authors:  Sevil Ari Yaylali; Fariz Sadigov; Hasan Erbil; Asiye Ekinci; Aylin Ardagil Akcakaya
Journal:  Int Ophthalmol       Date:  2013-03-02       Impact factor: 2.031

10.  Hydroxychloroquine retinopathy screening.

Authors:  A E Semmer; M S Lee; A R Harrison; T W Olsen
Journal:  Br J Ophthalmol       Date:  2008-10-01       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.